IDEX appoints Paris Watts-Stanfield to Board, effective Feb 25, 2022

IDEX CORP /DE/

Paris Watts-Stanfield appointed as director, effective February 25, 2022; board expands from 10 to 11 members.
She will serve on the Audit Committee; is VP & CFO Greater China at Medtronic.
Background includes corporate finance roles at Medtronic, Alcoa, Walmart, and Procter & Gamble.
Appointment supports IDEX's growth and ESG commitments per Chairman William Cook.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

L. Paris Watts-Stanfield

Director

IEX · IDEX CORP /DE/

Effective: 2022-02-25
Filed: February 28, 2022, 6:59 PM ET

On February 23, 2022, the Board of Directors (the “Board”) of IDEX Corporation (the “Company”) appointed L. Paris Watts-Stanfield to serve as a member of the Board and as a member of the Audit Committee of the Board, effective February 25, 2022, increasing the size of the Board from 10 to 11 members.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

L. Paris Watts-Stanfield was appointed as Director at IDEX CORP /DE/.

Action: appointed
Role: Director

Exact text from the filing

On February 23, 2022, the Board of Directors (the “Board”) of IDEX Corporation (the “Company”) appointed L. Paris Watts-Stanfield to serve as a member of the Board and as a member of the Audit Committee of the Board, effective February 25, 2022, increasing the size of the Board from 10 to 11 members.

View on SEC.gov

IDEX CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000832101-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.